Soft Tissue Allografts - A Global Strategic Business Report - new market research report published

companiesandmarkets.com

2012-11-23 10:40:27 - Soft Tissue Allografts - A Global Strategic Business Report - a new market research report on companiesandmarkets.com

The global market for soft tissue allografts is forecast to reach US$2.35 billion by the year 2015. Key factors driving market growth include emergence of tissue-engineered cartilage, stem cell technologies, collagen/cartilage-based implants, and scaffolds for the treatment of soft tissue problems. The market for soft tissue allografts will also be driven by rising demand for repair procedures associated to growth

 

 

in active lifestyles among affluent young population.

Aging population, increasing prevalence of degenerative joint diseases, rise in sports-related injuries, and improving orthopedic surgical procedures (such as arthroscopy) are contributing to the growth in orthopedic surgical volume. With constant rise in orthopedic surgical procedures, the demand for various orthopedic products is set to increase. Advent of numerous innovative products across various segments such as hip, spine and knee implants and the increased number of devices for extremities (arms, feet and hands) resulted in increased revenue generation for the orthopedics sector. The market also witnessed successful introduction of biologics, implants, and minimally invasive procedures for repairing of joints and big bones.

Soft tissue allografts continue to remain the largest contributor towards the total allografts market and projected to grow steadily over the next few years. Excellent product quality backed by numerous clinical studies has increased surgeons´ confidence and patient referrals to allograft options. The primary benefit of allografts is flexibility to choose from a wide range of suitable grafts and the ability to custom-fit prior to the surgery. Standard and machined allografts offer advantages, such as reduced pain, morbidity, and blood loss; lesser surgical time; lower procedural and hospital costs; improved rate of success; and better rehabilitation.

The United States represents the largest market for soft tissue allografts market, as stated by a new market research report on Soft Tissue Allografts. Following a period of turbulent times during the mid-2000s when the market was rocked by several controversies, the market is presently witnessing steady growth, with the US FDA taking several measures to re-establish public confidence on soft tissue allograft procedures. Europe represents the second largest market, and is expected to grow at a CAGR of more than 17% during the analysis period. Nevertheless, growth is expected to mainly emanate from the developing markets. Asia-Pacific is forecast to witness the fastest growth over the analysis period.

Tendon allografts is the largest segment in total soft tissue allografts market, with an estimated share of more than 45%. Cartilage Allografts represents the second largest market segment. Though tendon and cartilage allografts have been the traditional revenue contributors towards the total market, meniscus allografts market is projected to display a robust growth over the coming years, thereby proving to be the fastest growing segment in the total soft tissue allografts market.

The report titled Soft Tissue Allografts: A Global Strategic Business Report provides a comprehensive review of the soft tissue allografts market, soft tissue repair market, detailed analysis of the hernia repair market, current market trends, growth drivers, new product introductions and innovations, recent industry activity, and focus on major and niche global as well as regional market participants. The study analyzes market data and analytics in terms of value sales for global as well as regional markets including the US, Japan, Europe, Asia-Pacific, and Rest of World. Key product segments analyzed include Cartilage Allografts, Meniscus Allografts, and Tendon Allografts.

Key players profiled in the report include AlloSource, Conmed Corp., Cook Medical Inc., Covidien Public Limited Company, Genzyme Corp., LifeCell Corp., Lifelink Tissue Bank, RTI Biologics Inc., TEI Bioscience Inc., W. L. Gore & Associates Inc., and Zimmer, Inc. The report also include players in the soft tissue repair market, including Arthrex Inc., B. Braun Melsungen AG, Biosyntech Inc., Davol Inc., DePuy Inc., Ethicon Inc., Smith & Nephew Inc., Stryker Orthopaedics, Synovis Surgical Innovations, and United States Surgical Corp.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.